Literature DB >> 18695588

Use of statins and risk of hospitalization with dementia: a Danish population-based case-control study.

Henriette Thisted Horsdal1, Anne Vingård Olesen, Christiane Gasse, Henrik Toft Sørensen, Robert C Green, Søren Paaske Johnsen.   

Abstract

Several epidemiologic studies have indicated reduced risk of dementia among users of statins. We assessed the risk of hospitalization with dementia associated with use of statins in a population-based case-control study in 4 Northern Danish counties in the period 1991 to 2005. We identified 11,039 cases with dementia and 110,340 age- matched and sex-matched population controls using data from the National Patient Registry, the Danish Psychiatric Central Register, and the Civil Registration System. Prescriptions for statins filled before the admission for dementia were identified using population-based prescription databases. We used conditional logistic regression analysis to compute relative risk of hospitalization with dementia associated with use of statins using nonusers as reference group. We found an overall reduced risk of hospitalization with dementia among statin users (adjusted odds ratio: 0.67, 95% confidence intervals: 0.60-0.75). The reduced risk associated with statin use remained robust in various subanalyses, however, we found no clear dose-response pattern between the number of filled prescriptions for statin and the risk of hospitalization with dementia. In conclusion, we found a reduced risk of hospitalization with dementia among users of statins, however, whether this association is causal remains to be clarified.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18695588      PMCID: PMC3646360          DOI: 10.1097/WAD.0b013e318180f55b

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  41 in total

1.  The Danish prescription registries.

Authors:  D Gaist; H T Sørensen; J Hallas
Journal:  Dan Med Bull       Date:  1997-09

2.  Use of lipid-lowering drugs in older adults with and without dementia: a community-based epidemiological study.

Authors:  Eric G Rodriguez; Hiroko H Dodge; Maria A Birzescu; Gary P Stoehr; Mary Ganguli
Journal:  J Am Geriatr Soc       Date:  2002-11       Impact factor: 5.562

3.  Selective prescribing led to overestimation of the benefits of lipid-lowering drugs.

Authors:  Robert J Glynn; Sebastian Schneeweiss; Philip S Wang; Raia Levin; Jerry Avorn
Journal:  J Clin Epidemiol       Date:  2006-05-26       Impact factor: 6.437

4.  The Danish National Hospital Register. A valuable source of data for modern health sciences.

Authors:  T F Andersen; M Madsen; J Jørgensen; L Mellemkjoer; J H Olsen
Journal:  Dan Med Bull       Date:  1999-06

Review 5.  William M. Feinberg Lecture: Cognitive vitality and the role of stroke and cardiovascular disease risk factors.

Authors:  Philip B Gorelick
Journal:  Stroke       Date:  2005-02-24       Impact factor: 7.914

6.  Statins and the risk of dementia.

Authors:  H Jick; G L Zornberg; S S Jick; S Seshadri; D A Drachman
Journal:  Lancet       Date:  2000-11-11       Impact factor: 79.321

Review 7.  Alzheimer disease as a vascular disorder: nosological evidence.

Authors:  J C de la Torre
Journal:  Stroke       Date:  2002-04       Impact factor: 7.914

8.  Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

Authors:  Peter P Zandi; D Larry Sparks; Ara S Khachaturian; Joann Tschanz; Maria Norton; Martin Steinberg; Kathleen A Welsh-Bohmer; John C S Breitner
Journal:  Arch Gen Psychiatry       Date:  2005-02

9.  The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment.

Authors:  Ihab Hajjar; Jeannie Schumpert; Victor Hirth; Darryl Wieland; G Paul Eleazer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2002-07       Impact factor: 6.053

10.  Validity of dementia diagnoses in the Danish hospital registers.

Authors:  Thien Kieu Thi Phung; Birgitte Bo Andersen; Peter Høgh; Lars Vedel Kessing; Preben Bo Mortensen; Gunhild Waldemar
Journal:  Dement Geriatr Cogn Disord       Date:  2007-08-10       Impact factor: 2.959

View more
  11 in total

Review 1.  Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.

Authors:  Christiane Reitz
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 2.  Drug interactions with dementia-related pathophysiological pathways worsen or prevent dementia.

Authors:  Romain Barus; Johana Béné; Julie Deguil; Sophie Gautier; Régis Bordet
Journal:  Br J Pharmacol       Date:  2019-03-31       Impact factor: 8.739

Review 3.  Do Statins Have Antidepressant Effects?

Authors:  Ole Köhler-Forsberg; Christiane Gasse; Michael Berk; Søren Dinesen Østergaard
Journal:  CNS Drugs       Date:  2017-05       Impact factor: 5.749

4.  Cholesterol-independent neuroprotective and neurotoxic activities of statins: perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders.

Authors:  D Allan Butterfield; Eugenio Barone; Cesare Mancuso
Journal:  Pharmacol Res       Date:  2011-04-22       Impact factor: 7.658

Review 5.  Dyslipidemia and the risk of Alzheimer's disease.

Authors:  Christiane Reitz
Journal:  Curr Atheroscler Rep       Date:  2013-03       Impact factor: 5.113

Review 6.  Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.

Authors:  Marco Tuccori; Sabrina Montagnani; Stefania Mantarro; Alice Capogrosso-Sansone; Elisa Ruggiero; Alessandra Saporiti; Luca Antonioli; Matteo Fornai; Corrado Blandizzi
Journal:  CNS Drugs       Date:  2014-03       Impact factor: 5.749

7.  On cholesterol levels and statins in cognitive decline and Alzheimer disease: progress and setbacks.

Authors:  Marwan N Sabbagh; Kabir Thind; David Larry Sparks
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Oct-Dec       Impact factor: 2.703

8.  Statin Use, Incident Dementia and Alzheimer Disease in Elderly African Americans.

Authors:  Hugh C Hendrie; Ann Hake; Kathleen Lane; Christianna Purnell; Frederick Unverzagt; Valerie Smith-Gamble; Jill Murrell; Adesola Ogunniyi; Olusegun Baiyewu; Chris Callahan; Andrew Saykin; Stanley Taylor; Kathleen Hall; Su Gao
Journal:  Ethn Dis       Date:  2015-08-07       Impact factor: 1.847

9.  Systematic review of atorvastatin for the treatment of Alzheimer's disease.

Authors:  Yuan Sun; Genfa Wang; Zhihong Pan; Shuyan Chen
Journal:  Neural Regen Res       Date:  2012-06-15       Impact factor: 5.135

10.  Toward onset prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study protocol for a randomized controlled trial.

Authors:  Sally-Ann Cooper; Muriel Caslake; Jonathan Evans; Angela Hassiotis; Andrew Jahoda; Alex McConnachie; Jill Morrison; Howard Ring; John Starr; Ciara Stiles; Frank Sullivan
Journal:  Trials       Date:  2014-06-03       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.